An experimental treatment strategy for metastatic pancreatic cancer may help patients live longer by making tumors more visible to the immune system, according to a study published in Nature Medicine. OU Health Stephenson Cancer Center enrolled patients on the clinical trial, which studied a new drug called quemliclustat.
Wednesday, July 1, 2026 @ 1:00 PM - Wednesday, July 1, 2026 @ 2:00 PM
Zoom
Monday, July 20, 2026 @ 9:00 AM - Friday, July 24, 2026 @ 4:00 PM
College of Allied Health Building
Thursday, July 23, 2026 @ 8:00 AM - Thursday, July 23, 2026 @ 5:00 PM
The University of Oklahoma Health Campus
Tuesday, July 28, 2026 @ 3:00 PM - Tuesday, July 28, 2026 @ 4:00 PM
Wednesday, August 5, 2026 @ 1:00 PM - Wednesday, August 5, 2026 @ 2:00 PM